Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

trial · primary record

Cyclophosphamide

Core Binding Factor Alpha Subunits

PhasePhase 2
StatusRECRUITING
SponsorUnknown
Enrolment102
Primary completion2036-06-01
Primary endpointTo determine the proportion of participants with disease free survival at 1 year post haploidentical transplantation.
Registry IDNCT07524530

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:31:55.668Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07524530

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Cyclophosphamide — trial | AEaH